<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai Y</submitter><funding>NCI/NIH</funding><funding>American Cancer Society Research Scholar Grant</funding><funding>NIH</funding><funding>NIH HHS</funding><pagination>61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9590160</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Bile acids are known to be genotoxic and contribute to colorectal cancer (CRC). However, the link between CRC tumor bile acids to tumor location, patient sex, microbiome, immune-regulatory cells, and prognosis is not clear.&lt;h4>Methods&lt;/h4>We conducted bile acid analysis using targeted liquid chromatography-mass spectrometry (LC-MS) on tumor tissues from CRC patients (n = 228) with survival analysis. We performed quantitative immunofluorescence (QIF) on tumors to examine immune cells.&lt;h4>Results&lt;/h4>Twelve of the bile acids were significantly higher in right-sided colon tumors compared to left-sided colon tumors. Furthermore, in male patients, right-sided colon tumors had elevated secondary bile acids (deoxycholic acid, lithocholic acid, ursodeoxycholic acid) compared to </pubmed_abstract><journal>Biology of sex differences</journal><pubmed_title>Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.</pubmed_title><pmcid>PMC9590160</pmcid><funding_grant_id>1R21CA223686-01</funding_grant_id><funding_grant_id>134273-RSG-20-065-01-TBE</funding_grant_id><funding_grant_id>K12CA215110</funding_grant_id><funding_grant_id>R01CA256530</funding_grant_id><pubmed_authors>Rattray Z</pubmed_authors><pubmed_authors>Johnson CH</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Gaule P</pubmed_authors><pubmed_authors>Paty PB</pubmed_authors><pubmed_authors>Muca E</pubmed_authors><pubmed_authors>Khan SA</pubmed_authors><pubmed_authors>Lu L</pubmed_authors><pubmed_authors>Rattray NJW</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Cai Y</pubmed_authors><pubmed_authors>Theriot CM</pubmed_authors><pubmed_authors>Ahuja N</pubmed_authors><pubmed_authors>Shen X</pubmed_authors><pubmed_authors>Yan H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.</name><description>&lt;h4>Background&lt;/h4>Bile acids are known to be genotoxic and contribute to colorectal cancer (CRC). However, the link between CRC tumor bile acids to tumor location, patient sex, microbiome, immune-regulatory cells, and prognosis is not clear.&lt;h4>Methods&lt;/h4>We conducted bile acid analysis using targeted liquid chromatography-mass spectrometry (LC-MS) on tumor tissues from CRC patients (n = 228) with survival analysis. We performed quantitative immunofluorescence (QIF) on tumors to examine immune cells.&lt;h4>Results&lt;/h4>Twelve of the bile acids were significantly higher in right-sided colon tumors compared to left-sided colon tumors. Furthermore, in male patients, right-sided colon tumors had elevated secondary bile acids (deoxycholic acid, lithocholic acid, ursodeoxycholic acid) compared to </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T23:19:38.315Z</modification><creation>2025-04-04T23:19:38.315Z</creation></dates><accession>S-EPMC9590160</accession><cross_references><pubmed>36274154</pubmed><doi>10.1186/s13293-022-00473-9</doi></cross_references></HashMap>